Почетна › Рак бубрега (карцином бубрежних ћелија) › Тексас › Dallas
Kliničke studije za Рак бубрега (карцином бубрежних ћелија) u gradu Dallas, TX
24 studija za Рак бубрега (карцином бубрежних ћелија) traži učesnike na lokacijama u gradu Dallas i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Тражи се учесникФаза 3
- UT Southwestern Medical Center ( Site 0119), Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Тражи се учесникФаза 1
- NEO-811 Dallas Site, Dallas
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Тражи се учесникФаза 1
- University of Texas Southwestern Medical Center, Dallas
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Тражи се учесникФаза 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Тражи се учесникФаза 2
- University of Texas Southwestern Medical Center, Dallas
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Тражи се учесникФаза 2
- UT Southwestern Medical Center, Dallas
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Тражи се учесникФаза 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Тражи се учесникФаза 1
- UT Southwestern Simmons Cancer Center, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Тражи се учесникФаза 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- и још 2
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Тражи се учесникФаза 3
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Тражи се учесникФаза 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #89, Dallas
DESTINY-PANTUMOUR04
Тражи се учесникОпсервациона студија
- Research Site, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Тражи се учесникФаза 1/2
- Baylor, Scott and White Research Institute, Dallas
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Тражи се учесникФаза 2
- University of Texas Southwestern Medical Center, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Тражи се учесникОпсервациона студија
- UT Southwestern Medical Center, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Mary Crowley Cancer Research, Dallas
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Тражи се учесникФаза 2
- University of Texas, Southwestern Medical Center, Dallas
PET/MR for Characterization of Renal Masses (RMs)
Тражи се учесникОпсервациона студија
- University of Texas Southwestern Medical Center, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Тражи се учесникФаза 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
Тражи се учесникФаза 1
- Mary Crowley Cancer Research, Dallas
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Тражи се учесникЗдраве особе су добродошле
- University of Texas Southwestern Medical Center, Dallas
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Тражи се учесникФаза 1
- UT Southwestern Medical Center, Dallas
Studije za Рак бубрега (карцином бубрежних ћелија) u drugim gradovima
- Houston, TX34 студија
- New York City, NY29 студија
- St. Louis, MO25 студија
- Nashville, TN24 студија
- Los Angeles, CA22 студија
- Boston, MA16 студија
- Philadelphia, PA16 студија
- Queens, NY16 студија
- Pittsburgh, PA15 студија
- Baldwin Park, CA15 студија
- Edison, NJ14 студија
- Rochester, MN14 студија
Ostale studije u gradu Dallas
- Рак дојке54 студија
- Немалоклетни карцином плућа53 студија
- Метастатски карцином44 студија
- Затајење срца42 студија
- Рак (све врсте)40 студија
- Рак простате39 студија
- Колоректални карцином34 студија
- Гојазност33 студија
- Рак јајника31 студија
- Рак бешике27 студија
- Рак плућа26 студија
- Карцином ендометријума25 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.